Interaction exists between matriptase inhibitors and intestinal epithelial cells

References

• Berkes J, Viswanathan VK, Savkovic SD, Hecht G. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 2003;52:439–51
   PubMed Web of Science ®Google Scholar
• DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 2002;34:385–96
   PubMed Web of Science ®Google Scholar
• Goto Y, Kiyono H. Epithelial barrier: an interface for the cross-communication between gut flora and immune system. Immunol Rev 2012;245:147–63
   PubMed Web of Science ®Google Scholar
• Paszti-Gere E, Barna RF, Kovago C, Szauder I, et al. Changes in the distribution of type II transmembrane serine protease, TMPRSS2 and in paracellular permeability in IPEC-J2 cells exposed to oxidative stress. Inflammation 2015;38:775–83
   PubMed Web of Science ®Google Scholar
• Geens MM, Niewold TA. Optimizing culture conditions of a porcine epithelial cell line IPEC-J2 through a histological and physiological characterization. Cytotechnology 2011;63:415–23
   PubMed Web of Science ®Google Scholar
• Cencic A, Langerholc T. Functional cell models of the gut and their applications in food microbiology – a review. Int J Food Microbiol 2010;141:4–14
   PubMed Web of Science ®Google Scholar
• Berschneider HM. Development of normal cultured small intestinal epithelial cell lines which transport Na and Cl. Gastroenterology 1989;96:A41
   Google Scholar
• Schierack P, Nordhoff M, Pollmann M, et al. Characterization of a porcine intestinal epithelial cell line for in vitro studies of microbial pathogenicesis in swine. Histochem Cell Biol 2006;125:293–305
   PubMed Web of Science ®Google Scholar
• Benaud C, Oberst M, Hobson JP, et al. Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase. J Biol Chem 2002;277:10539–46
   PubMed Web of Science ®Google Scholar
• List K, Bugge TH, Szabo R. Matriptase: potent proteolysis on the cell surface. Mol Med 2006;12:1–7
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Harris JL, Huang W, et al. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 2000;275:26333–42
   PubMed Web of Science ®Google Scholar
• List K, Kosa P, Szabo R, et al. Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway. Am J Pathol 2009;175:1453–63
   PubMed Web of Science ®Google Scholar
• Förbs D, Thiel S, Stella MC, et al. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma. Int J Oncol 2005;27:1061–70
   PubMed Web of Science ®Google Scholar
• Milner JM, Patel A, Davidson RK, et al. Matriptase is a novel initiator of cartilage matrix degradation in osteoarthritis. Arthritis Rheum 2010;62:1955–66
   PubMed Web of Science ®Google Scholar
• Böttcher-Friebertshäuser E, Freuer C, Sielaff F, et al. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J Virol 2010;84:5605–14
   PubMed Web of Science ®Google Scholar
• Hamilton BS, Gludish DW, Whittaker GR. Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities. J Virol 2012;86:10579–86
   PubMed Web of Science ®Google Scholar
• Hammami M, Rühmann E, Maurer E, et al. New 3-amidinophenylalanine-derived inhibitors of matriptase. Med Chem Commun 2012;3:807–13
   Web of Science ®Google Scholar
• Meyer D, Sielaff F, Hammami M, et al. Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation. Biochem J 2013;452:331–43
   PubMed Web of Science ®Google Scholar
• Steinmetzer T, Schweinitz A, Stürzebecher A, et al. Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase. J Med Chem 2006;49:4116–26
   PubMed Web of Science ®Google Scholar
• Steinmetzer T, Dönnecke D, Korsonewski M, et al. Modification of the N-terminal sulfonyl residue in 3-amidinophenylalanine-based matriptase inhibitors. Bioorg Med Chem Lett 2009;19:67–73
   PubMed Web of Science ®Google Scholar
• Schweinitz A, Dönnecke D, Ludwig A, et al. Incorporation of neutral C-terminal residues in 3-amidinophenylalanine-derived matriptase inhibitors. Bioorg Med Chem Lett 2009;19:1960–5
   PubMed Web of Science ®Google Scholar
• Colombo E, Désilets A, Duchêne D, et al. Design and synthesis of potent, selective inhibitors of matriptase. ACS Med Chem Lett 2012;3:530–4
   PubMed Web of Science ®Google Scholar
• Duchêne D, Colombo E, Désilets A, et al. Analysis of subpocket selectivity and identification of potent selective inhibitors for matriptase and matriptase-2. J Med Chem 2014;57:10198–204
   PubMed Web of Science ®Google Scholar
• Galkin AV, Mullen L, Fox WD, et al. CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts. Prostate 2004;3:228–35
   Web of Science ®Google Scholar
• Buzza MS, Netzel-Arnett S, Shea-Donohue T, et al. Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc Natl Acad Sci USA 2010;107:4200–5
   PubMed Web of Science ®Google Scholar
• Buzza MS, Martin EW, Driesbaugh KH, et al. Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway. J Biol Chem 2013;288:10328–37
   PubMed Web of Science ®Google Scholar
• Chu LL, Xu Y, Yang JR, et al. Human cancer cells retain modest levels of enzymatically active matriptase only in extracellular milieu following induction of zymogen activation. PLoS One 2014;9:e92244
   PubMed Web of Science ®Google Scholar
• Oberst MD, Singh B, Ozdmirli M, et al. Characterisation of matriptase expression in normal human tissues. J Histochem Cytochem 2003;51:1017–25
   PubMed Web of Science ®Google Scholar
• Szabo R, Hobson JP, List K, et al. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity. J Biol Chem 2008;283:29495–504
   PubMed Web of Science ®Google Scholar